Bausch Health Companies Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • BHC
  • 1d-1.48%
  • 1w-6.80%
  • 1m-6.20%
  • 1y15.22%
ATH
  • ATH Price$262.52
  • ATH Date2015-08-05
  • % since ATH-96.71%
  • % to ATH2,941.95%
ATL
  • ATL Price$0.24
  • ATL Date1994-04-19
  • % from ATL3,519.97%
  • Last Low Price$4.58
  • Last Low Date2022-08-02
  • % From Last Low88.43%
IPO
  • IPO Price$6.00
  • % Current ROI USD143.83%
  • ATH Price$262.52
  • % ROI ATH 11,011,744.97%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="BHC"]

Key Data [addtoany]

Current price $8.63
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $8.98/$8.565
Volume 3,172,941.00
Previous Close $8.76
52 Week High/Low $11.46/$5.5703
Market Cap 3,233,272,320.00
P/E Ratio 0
Forward P/E 1 Yr. $2.41
Earnings Per Share(EPS) $3.99
Annualized Dividend $0
$8.63
[addtoany]

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.
The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products.
The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East.
The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally.
The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States.
The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity